Naltrexone hydrochloride (CAS 16676-29-2) is a potent opioid receptor antagonist and anti-addictive API, renowned for its targeted action in blocking opioid effects and supporting addiction recovery. Its unique molecular structure binds competitively to mu, delta, and kappa opioid receptors in the brain, preventing opioids from exerting euphoric and addictive effects while reducing cravings. This high-purity pharmaceutical raw material complies with strict international pharmacopoeial standards, ensuring consistent potency and stability for clinical formulation.